Detalhe da pesquisa
1.
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma.
Blood
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484137
2.
Simultaneous targeting of B-cell malignancies and human immunodeficiency virus with bispecific chimeric antigen receptor T cells.
Haematologica
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779743
3.
CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR-refractory large B-cell lymphoma.
Blood
; 137(17): 2321-2325, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512414
4.
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma.
Am J Hematol
; 98(11): 1751-1761, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668287
5.
A Primer on Chimeric Antigen Receptor T-cell Therapy-related Toxicities for the Intensivist.
J Intensive Care Med
; : 8850666231205264, 2023 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37899577
6.
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.
Br J Haematol
; 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797530
7.
Lactate dehydrogenase to carboxyhemoglobin ratio as a biomarker of heme release to heme processing is associated with higher tricuspid regurgitant jet velocity and early death in sickle cell disease.
Am J Hematol
; 96(9): E315-E318, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000072
8.
Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide.
Br J Haematol
; 168(5): 737-46, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25377027
9.
Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma.
Blood Adv
; 8(6): 1474-1486, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38295285
10.
COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies.
Am Soc Clin Oncol Educ Book
; 43: e390778, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163714
11.
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma.
Cancers (Basel)
; 15(6)2023 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980632
12.
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Cancer Cell
; 41(1): 210-225.e5, 2023 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584673
13.
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy.
Nat Med
; 28(9): 1860-1871, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097223
14.
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma.
Blood Adv
; 5(1): 143-155, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33570626
15.
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial.
Nat Med
; 27(8): 1419-1431, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312556
16.
Voriconazole-induced periostitis after allogeneic stem cell transplantation.
Am J Hematol
; 90(6): 574-5, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683739
17.
An Unusual Cause of Epistaxis: Paranasal Sinus Myeloid Sarcoma.
Case Rep Hematol
; 2019: 1312630, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30891319
18.
A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis.
Blood Adv
; 3(15): 2264-2271, 2019 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350306
19.
Clinical Validation of KIT Inhibition in Advanced Systemic Mastocytosis.
Curr Hematol Malig Rep
; 13(5): 407-416, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30155614
20.
Interferon-γ blockade in CAR T-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis.
Blood Adv
; 7(4): 533-536, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917457